Please check your internet connection and try again.
## Hepamerz (L-Ornithine L-Aspartate)
### Overview
Hepamerz is a combination of the amino acids L-ornithine and L-aspartate. It is thought to reduce ammonia levels by promoting its detoxification in the liver and kidneys.
### Primary Indications
* Treatment of latent and manifest hepatic encephalopathy (HE) associated with hyperammonemia in patients with cirrhosis.
### Adult Dosing
* **Initial dose:** 17 grams orally per day, divided into three doses (e.g., 6 grams in the morning, 6 grams at noon, 5 grams in the evening).
* **Maintenance dose:** Varies depending on patient response and tolerance, typically 6-18 grams orally per day.
* **Intravenous (IV) administration:** In cases of severe HE or when oral administration is not feasible, IV formulations may be used, often at doses of 10-20 grams per day. Dosing should be guided by local protocols and patient response.
### Pediatric Dosing
* There is **limited established pediatric dosing** for Hepamerz. Use in pediatric populations should be based on expert clinical judgment and available literature, with caution.
### Dose Adjustments
* **Renal Impairment:** No specific dose adjustments are commonly recommended, but caution is advised. Monitor ammonia and renal function closely.
* **Hepatic Impairment:** The drug is intended for patients with liver disease; however, response should be closely monitored.
### Contraindications
* Severe renal insufficiency (creatinine clearance <30 mL/min).
* Hypersensitivity to L-ornithine, L-aspartate, or any component of the formulation.
### Adverse Effects
* **Gastrointestinal:** Nausea, vomiting, diarrhea, abdominal discomfort.
* **Neurological:** Dizziness, headache.
* **Other:** Rarely, allergic reactions.
### Key Drug Interactions
* No significant drug interactions are well-established. However, caution should be exercised when co-administering with other medications that affect ammonia metabolism or renal function.
### Monitoring
* **Ammonia levels:** Monitor serum ammonia levels to assess efficacy.
* **Renal function:** Monitor serum creatinine and BUN, especially in patients with pre-existing renal impairment.
* **Hepatic function:** Monitor liver enzymes and clinical signs of liver disease.
* **Clinical signs of HE:** Assess mental status, confusion, and neurological deficits.
### Clinical Pearls
* Oral administration is preferred when possible.
* Dividing the daily dose can improve gastrointestinal tolerance.
* Treatment duration depends on the severity of HE and patient response.
* Hepamerz is a supportive therapy and does not replace definitive management of the underlying liver disease.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and local institutional protocols for complete and up-to-date guidance.*
